Changes in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis

F Luzza1, T Parrello, G Monteleone

  • 1Dipartimento di Medicina Sperimentale e Clinica, Università di Catanzaro Magna Graecia, Italy.

Insights

Interleukin-15 (IL-15) is expressed in the gastric mucosa. Helicobacter pylori infection may suppress IL-15 levels, which increase after successful eradication, suggesting a role for IL-15 in H. pylori-associated gastritis.

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • Interleukin-15 (IL-15) is a cytokine crucial for immune cell development and function.
  • Gastric mucosal inflammation is a hallmark of Helicobacter pylori infection.
  • The role of IL-15 in H. pylori-induced gastritis is not well understood.

Purpose of the Study:

  • To investigate the expression of IL-15 in the human gastric mucosa.
  • To determine the association between IL-15 levels and H. pylori infection status.
  • To explore the changes in IL-15 expression following H. pylori eradication therapy.

Main Methods:

  • Detection of IL-15 transcripts and protein in gastric mucosal biopsies.
  • Comparison of IL-15 expression in H. pylori-positive and H. pylori-negative individuals.
  • Assessment of IL-15 levels before and after successful H. pylori eradication.

Main Results:

  • IL-15 transcripts were detected in 100% of H. pylori-negative patients and 28% of H. pylori-positive patients.
  • IL-15 mRNA and protein were found in 17% of patients before eradication and 83% after successful eradication.
  • Gastritis scores improved significantly after eradication, but IL-15 expression did not correlate with gastritis severity in H. pylori-infected patients.

Conclusions:

  • This study provides the first evidence of IL-15 expression in the human gastric mucosa.
  • H. pylori infection appears to down-regulate IL-15 expression in the gastric mucosa.
  • IL-15 levels increase after successful H. pylori eradication, suggesting a potential role in gastritis resolution.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...